These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 32508294

  • 1. DNA damage checkpoint kinases in cancer.
    Smith HL, Southgate H, Tweddle DA, Curtin NJ.
    Expert Rev Mol Med; 2020 Jun 08; 22():e2. PubMed ID: 32508294
    [Abstract] [Full Text] [Related]

  • 2. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
    Vera J, Raatz Y, Wolkenhauer O, Kottek T, Bhattacharya A, Simon JC, Kunz M.
    Cell Signal; 2015 May 08; 27(5):951-60. PubMed ID: 25683911
    [Abstract] [Full Text] [Related]

  • 3. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G, Besnard E, Fisher D, Piette J, Dulić V.
    Oncogene; 2011 Oct 13; 30(41):4261-74. PubMed ID: 21532626
    [Abstract] [Full Text] [Related]

  • 4. N-nitroso-N-ethylurea activates DNA damage surveillance pathways and induces transformation in mammalian cells.
    Bodakuntla S, Libi AV, Sural S, Trivedi P, Lahiri M.
    BMC Cancer; 2014 Apr 24; 14():287. PubMed ID: 24758542
    [Abstract] [Full Text] [Related]

  • 5. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
    Helt CE, Cliby WA, Keng PC, Bambara RA, O'Reilly MA.
    J Biol Chem; 2005 Jan 14; 280(2):1186-92. PubMed ID: 15533933
    [Abstract] [Full Text] [Related]

  • 6. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J, Tho LM, Xu N, Gillespie DA.
    Adv Cancer Res; 2010 Jan 14; 108():73-112. PubMed ID: 21034966
    [Abstract] [Full Text] [Related]

  • 7. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
    Gatei M, Sloper K, Sorensen C, Syljuäsen R, Falck J, Hobson K, Savage K, Lukas J, Zhou BB, Bartek J, Khanna KK.
    J Biol Chem; 2003 Apr 25; 278(17):14806-11. PubMed ID: 12588868
    [Abstract] [Full Text] [Related]

  • 8. Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets.
    Khamidullina AI, Abramenko YE, Bruter AV, Tatarskiy VV.
    Int J Mol Sci; 2024 Jan 19; 25(2):. PubMed ID: 38279263
    [Abstract] [Full Text] [Related]

  • 9. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
    Yan T, Desai AB, Jacobberger JW, Sramkoski RM, Loh T, Kinsella TJ.
    Mol Cancer Ther; 2004 Sep 19; 3(9):1147-57. PubMed ID: 15367709
    [Abstract] [Full Text] [Related]

  • 10. Targeting DNA checkpoint kinases in cancer therapy.
    Zhou BB, Anderson HJ, Roberge M.
    Cancer Biol Ther; 2003 Sep 19; 2(4 Suppl 1):S16-22. PubMed ID: 14508077
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells.
    Mak JP, Man WY, Chow JP, Ma HT, Poon RY.
    Oncotarget; 2015 Aug 28; 6(25):21074-84. PubMed ID: 26025928
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G₂/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.
    Kim JY, Choi HE, Lee HH, Shin JS, Shin DH, Choi JH, Lee YS, Lee KT.
    Oncol Rep; 2015 May 28; 33(5):2639-47. PubMed ID: 25812484
    [Abstract] [Full Text] [Related]

  • 13. Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest.
    Morii M, Fukumoto Y, Kubota S, Yamaguchi N, Nakayama Y, Yamaguchi N.
    Cell Biol Int; 2015 Aug 28; 39(8):923-32. PubMed ID: 25790472
    [Abstract] [Full Text] [Related]

  • 14. Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress.
    Yan S, Sorrell M, Berman Z.
    Cell Mol Life Sci; 2014 Oct 28; 71(20):3951-67. PubMed ID: 24947324
    [Abstract] [Full Text] [Related]

  • 15. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
    Lee HJ, Hwang HI, Jang YJ.
    Cell Cycle; 2010 Jun 15; 9(12):2389-98. PubMed ID: 20581453
    [Abstract] [Full Text] [Related]

  • 16. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
    Pabla N, Huang S, Mi QS, Daniel R, Dong Z.
    J Biol Chem; 2008 Mar 07; 283(10):6572-83. PubMed ID: 18162465
    [Abstract] [Full Text] [Related]

  • 17. PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells.
    Yuan Z, Guo W, Yang J, Li L, Wang M, Lei Y, Wan Y, Zhao X, Luo N, Cheng P, Liu X, Nie C, Peng Y, Tong A, Wei Y.
    J Biol Chem; 2015 Jun 12; 290(24):14927-44. PubMed ID: 25918161
    [Abstract] [Full Text] [Related]

  • 18. Src family kinases promote silencing of ATR-Chk1 signaling in termination of DNA damage checkpoint.
    Fukumoto Y, Morii M, Miura T, Kubota S, Ishibashi K, Honda T, Okamoto A, Yamaguchi N, Iwama A, Nakayama Y, Yamaguchi N.
    J Biol Chem; 2014 May 02; 289(18):12313-29. PubMed ID: 24634213
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.
    Koppenhafer SL, Goss KL, Terry WW, Gordon DJ.
    Mol Cancer Res; 2020 Jan 02; 18(1):91-104. PubMed ID: 31649026
    [Abstract] [Full Text] [Related]

  • 20. Osteoblasts survive the arsenic trioxide treatment by activation of ATM-mediated pathway.
    Hu YC, Hsieh BS, Cheng HL, Huang LW, Huang TC, Huang IY, Chang KL.
    Biochem Pharmacol; 2013 Apr 01; 85(7):1018-26. PubMed ID: 23337567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.